87 related articles for article (PubMed ID: 17057771)
21. Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening?
Ferretti G; Bria E; Carlini P; Felici A; Giannarelli D; Cuppone F; Papaldo P; Nisticò C; Fabi A; Gelibter A; Terzoli E; Cognetti F
Gut; 2005 Jun; 54(6):891. PubMed ID: 15888808
[No Abstract] [Full Text] [Related]
22. [Problems and prospects of non-invasive screening for colorectal cancer].
Maev IV; Govorun VM; Kucheriavyĭ IuA; Golubev NN; Generozov EV; Maslov VV; LiubeznovA IIu; Kostin PA
Klin Med (Mosk); 2009; 87(7):10-6. PubMed ID: 19705783
[TBL] [Abstract][Full Text] [Related]
23. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
[TBL] [Abstract][Full Text] [Related]
24. New gene discoveries may boost DNA stool testing for colorectal cancer.
Garber K
J Natl Cancer Inst; 2004 Jun; 96(11):820-1. PubMed ID: 15173262
[No Abstract] [Full Text] [Related]
25. Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: a new screening concept for colorectal cancer.
Ewald N; Schaller M; Bayer M; Akinci A; Bretzel RG; Kloer HU; Hardt PD
Anticancer Res; 2007; 27(4A):1949-52. PubMed ID: 17649802
[TBL] [Abstract][Full Text] [Related]
26. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P
Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678
[TBL] [Abstract][Full Text] [Related]
27. The role of stool DNA analysis in the early detection and screening of colorectal cancer.
Chu E
Clin Colorectal Cancer; 2003 May; 3(1):9. PubMed ID: 12777186
[No Abstract] [Full Text] [Related]
28. Evaluation of calgranulin B in stools from the patients with colorectal cancer.
Yoo BC; Shin YK; Lim SB; Hong SH; Jeong SY; Park JG
Dis Colon Rectum; 2008 Nov; 51(11):1703-9. PubMed ID: 18584251
[TBL] [Abstract][Full Text] [Related]
29. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
[TBL] [Abstract][Full Text] [Related]
30. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
[TBL] [Abstract][Full Text] [Related]
31. Which colorectal cancer screening test is best?
Mandel JS
J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
[No Abstract] [Full Text] [Related]
32. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces.
Onouchi S; Matsushita H; Moriya Y; Akasu T; Fujita S; Yamamoto S; Hasegawa H; Kitagawa Y; Matsumura Y
Anticancer Res; 2008; 28(1A):145-50. PubMed ID: 18383838
[TBL] [Abstract][Full Text] [Related]
33. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
34. Stool test identifies markers for colorectal cancer, studies show.
Wang L
J Natl Cancer Inst; 2002 Mar; 94(5):332-3. PubMed ID: 11880472
[No Abstract] [Full Text] [Related]
35. Colorectal cancer screening: prospects for molecular stool analysis.
Davies RJ; Miller R; Coleman N
Nat Rev Cancer; 2005 Mar; 5(3):199-209. PubMed ID: 15738983
[TBL] [Abstract][Full Text] [Related]
36. Faecal screening of colorectal cancer.
Loganayagam A
Int J Clin Pract; 2008 Mar; 62(3):454-9. PubMed ID: 17887994
[TBL] [Abstract][Full Text] [Related]
37. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis of malignant colorectal neoplasms by means of molecular genetic analysis of fecal DNA].
Lantsov VA; Vostriukhina OA
Vopr Onkol; 2005; 51(2):167-72. PubMed ID: 16222995
[No Abstract] [Full Text] [Related]
39. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
